Clinical Trial

Latent Tuberculosis Infection Screening Using QuantiFERON at Pre-Employment Assessment in Hospital Workers CHu Nice

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 27, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This retrospective observational single-center study aims to evaluate the medical and occupational relevance of systematic screening for latent tuberculosis infection using QuantiFERON-TB Gold Plus during pre-employment occupational health assessment among hospital workers at the University Hospital of Nice. Data will be collected retrospectively from occupational health medical records, immunology laboratory results and, when necessary, data from specialized follow-up by the tuberculosis control center. The primary objective is to determine the proportion of positive QuantiFERON-TB Gold Plus tests at pre-employment screening. Secondary objectives are to identify factors associated with a positive test, to describe the practical consequences of screening, including chest X-ray, diagnosis of latent tuberculosis infection and initiation of preventive treatment, and to estimate the cost of systematic screening.
Trial Details
NCT Number NCT07608601
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Latent Tuberculosis Infection
Enrollment 1,185 participants
Start Date 2026-06-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-27